Today is Melanoma Monday

Article

Katherine Lagomarsino blog image

It's not too late! There is still time to wear orange today to both raise awareness about skin cancer and also encourage early detection through self-exam. The American Academy of Dermatology (AAD) created Melanoma Monday to help get the word out about not only melanoma, but all skin cancers. Following are a few stats about skin cancer from the AAD: It's the most common cancer in the U.S.; it is estimated that one in five people will receive a diagnosis of skin cancer in their lifetime; and melanoma is the most common type of cancer in people age 25 to 29. For their SPOT Orange campaign, the AAD is asking the public to submit photos of friends, family, co-workers or even pets wearing orange in honor of Melanoma Monday. You can upload the photos here. So hurry up and get your orange on!

Related Videos
Image of a woman with short blonde hair wearing a white blazer.
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey. If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key. “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained. READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Yuliya P.L Linhares, MD, an expert on CLL
Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL
Image of a man with a beard.
Related Content
Image of a person holding a yellow flower.

Not Giving Into the Fear Cancer Brings

April 30th 2024
Article

Accepting both my beauty and flaws helps me push away the fear cancer brings.

Read More

cancer horizons logo: a white microphone on a navy blue background

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

March 11th 2024
Podcast

Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.

Listen

Site Logo

From Walls To Balls: The Testicular Cancer Society’s New Awareness Campaign is a Belter

April 30th 2024
Article

How to do your self-examination while catching your favorite footy highlights

Read More

cancer horizons podcast logo: a white microphone on a blue background

Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

March 4th 2024
Podcast

In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, and how to manage them.

Listen

Illustration of a man with short black hair and rectangular glasses.

Recognizing and Managing Stress from Cancer

April 30th 2024
Article

I need to acknowledge and address the impact stress from multiple myeloma has on my mental and emotional wellbeing.

Read More

Image of a tumor in the right lung.

‘Landmark’ Findings Led to Alecensa Approval for ALK-Positive NSCLC

April 30th 2024
Article

Alecensa was shown to reduce the risk of disease recurrence or death by 76% versus chemotherapy for patients with ALK-positive non-small cell lung cancer.

Read More